Medicon Valley Biomedical Newsletter

ALK-Abelló A/S has completed the European Mutual Recognition Procedure for GRAZAX, the company's tablet-based vaccine against grass pollen allergy, and authorities in 27 European countries have no...

Alligator Bioscience AB and AlgoNomics NV have announced that they have entered into a collaboration. AlgoNomics will employ its Epibase platform to complement Alligator Bioscience in the optimization...

Astion Pharma A/S has initiated its first clinical study with ASF-1096 in patients suffering from Discoid Lupus Erythematosus, DLE. DLE is a scarring skin disease affecting two to three in every 10,00...

Bavarian Nordic A/S has announced that the company has initiated a Phase I and a Phase I/II clinical study in Europe with MVA-BN polytope vaccine against HIV. The vaccine was recently released from th...

BioGaia AB has signed a distribution agreement with Ewopharma AG, Switzerland, which gives Ewopharma exclusive rights to distribute BioGaia´s Probiotic drops and tablets in a number of countri...

Curalogic A/S and SAFC Inc. have signed an agreement on the production of house dust mite extracts, which are the active substances in Curalogic's oral immunotherapy product for treating allergy t...

Dako A/S's Microbiology business has been acquired by Oxoid, a business unit within the Fisher Biosciences group and one of the world's leading manufacturers of microbiological culture media a...

Exiqon A/S, a leading supplier of high-value gene expression analysis products, and Luminex Corporation, a leading multiplex solution developer, have announced the signing of an agreement to co-develo...

Exiqon A/S has announced it is expanding its US presence by opening a sales, distribution and technical support facility in the heart of the Boston, MA biotech community. The new entity, Exiqon, Inc.,...

Genovis AB is launching its first product, a system for cell delivery of biomolecules. Genovis which is listed on the First North stock exchange is now launching its system for Nano Induced Mag...

LifeCycle Pharma A/S has announced that it has entered into three strategic collaboration agreements with leading players in the pharmaceutical industry. These companies are Sandoz Inc., an affiliate ...

The venture capital company Innovationskapital is investing Euro 320,000 in the Lund-based bioinformatics company, Ludesi AB. This extra funding will help Ludesi to roll out sales of 2D electro...

Lund University, Innovationsbron and Ideon Science Park have in collaboration established a new bioincubator to promote and help new innovation projects by creating an environment that improves develo...

H. Lundbeck A/S has initiated phase I clinical trials with the pharmaceutical candidate Lu AA44608 to investigate safety, tolerability and the pharmacokinetic profile of the compound in humans. ...

NatImmune A/S has announced that they have acquired Nya Hamlet Pharma, a privately heldcompany based in Lund, Sweden. Nya Hamlet Pharma specializes in development of protein derived compounds for canc...

Nycomed A/S has announced that it has reached an agreement to acquire Altana Pharma AG. The transaction has a total value of Euro 4.215 billion and will be financed by new equity and committed ...

PhaseOneTrials A/S has initiated a phase I study investigating the safety, tolerability, pharmacokinetics and pharmacodynamics of a new investigational compound after a single subcutaneous injection i...

TopoTarget A/S, the Danish biotechnology company, announces the launch of Savene, which the company believes will be the 'gold standard' treatment for accidental tissue exposure to anthracycli...